Biomark Diagnostics (XCNQ:BUX) Long-Term Debt : C$0.00 Mil (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Biomark Diagnostics Long-Term Debt?

Biomark Diagnostics's Long-Term Debt for the quarter that ended in Sep. 2024 was C$0.00 Mil.

Biomark Diagnostics's annual Long-Term Debt declined from Mar. 2022 (C$0.10 Mil) to Mar. 2023 (C$0.00 Mil) but then stayed the same from Mar. 2023 (C$0.00 Mil) to Mar. 2024 (C$0.00 Mil).

Biomark Diagnostics Long-Term Debt Historical Data

The historical data trend for Biomark Diagnostics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Long-Term Debt Chart

Biomark Diagnostics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Debt

Get a 7-Day Free Trial

0.09

0.10

Biomark Diagnostics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Debt	Get a 7-Day Free Trial															-	-	-	-	-

Biomark Diagnostics (XCNQ:BUX) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Biomark Diagnostics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomark Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (XCNQ:BUX) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

BMKDF:USA 20B:Germany

Address

130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2

Website

https://www.biomarkdiagnostics.com

Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early cancer treatment. Its research and development are focused on the role that metabolomics plays in early cancer detection. The company's objective is to commercialize its inventive technology. and strive to increase the predictive accuracy in early-stage cancer detection.

Executives

Guoyu Huang	Senior Officer
Rashid Ahmed Maula Bux	Director

Biomark Diagnostics Headlines

No Headlines